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OBJECTIVE—Type 2 diabetes is caused by both environmental
and genetic factors. To better understand the genetic factors we
used forward genetics to discover genes that have not previously
been implicated in the development of hyperglycemia or
diabetes.
RESEARCH DESIGN AND METHODS—Offspring of ethylni-
trosurea-mutagenized C57BL/6 mice were bred to homozygosity,
maintained on high-fat diet, and screened for hyperglycemia. The
phenotype in one diabetic family of mice was mapped among
hybrid F2s with single nucleotide polymorphic markers, followed
by candidate gene sequencing to identify the gene harboring the
causative mutation. Subsequent analysis was done on wild-type,
heterozygous, and homozygous mutant mice on a pure C57BL/6
background.
RESULTS—Diabetes mapped to a point mutation in the Sec61a1
gene that encodes a His to Tyr substitution at amino acid 344
(Y344H). Metabolic proﬁling, histological examination, and elec-
tron microscopy revealed that hyperglycemia was a result of
insulin insufﬁciency due to -cell apoptosis brought on by
endoplasmic reticulum (ER) stress. Transgenic -cell–speciﬁc
expression of Sec61a1 in mutant mice rescued diabetes, -cell
apoptosis, and ER stress. In vitro experiments showed that
Sec611 plays a critical role in the -cell response to glucose.
CONCLUSIONS—Here we phenotypically characterize diabe-
tes in mice with a novel point mutation in a basic component of
the cell’s ER protein translocation machinery, Sec611. Translo-
cation by the mutant protein does not appear to be affected.
Rather, ER homeostasis is perturbed leading to -cell death and
diabetes. Diabetes 59:460–470, 2010
T
ype 2 diabetes, a signiﬁcant and growing cause
of morbidity and mortality worldwide, is a result
of defects in secretion of insulin and its effects
on peripheral tissues. Epidemiological evidence
makes it clear that -cell deﬁciency, as measured by
insulin secretion, is a risk factor for the development of
type 2 diabetes (1). The precise nature of the -cell defect
that normally accompanies type 2 diabetes however re-
mains unclear.
Although environmental factors have played a key role
in the recent increases in type 2 diabetes, it is clear from
epidemiological and recent genome-wide association stud-
ies that there is a strong genetic component (2–5). It is also
apparent, from genome-wide association studies, that the
genetic component of diabetes is spread across many
genes, and that associations discovered to date are by no
means an exhaustive list of genes that could carry poly-
morphisms that contribute to diabetes.
The strength of forward genetic screens lies in their
ability to ﬁnd novel genes involved in biological processes
by focusing on speciﬁc phenotypes. Mutagenesis projects
have been used in many model organisms such as yeast,
Drosophila, worms, zebra ﬁsh, and, more recently, mice.
Inducing germ-line point mutations by ethylnitrosurea
(ENU) has led to the identiﬁcation of genes involved in
mammalian circadian rhythms (6), neuronal development
(7), inﬂammation/autoimmunity (8), and cataract develop-
ment (9). ENU mutagenesis has also been applied to the
study of diabetes. Using ENU, Toye et al. (10) isolated a
mutation in glucokinase, a gene commonly mutated in
maturity-onset diabetes of the young, indicating that this
method has the potential to uncover genes that are phys-
iologically relevant to the etiology of metabolic disorders.
In this report we describe a novel strain of diabetic
mice, caused by an ENU-induced point mutation in
Sec61a1. We found hyperglycemia to be temporally linked
with -cell loss and show a mechanistic link to endoplas-
mic reticulum (ER) stress-induced apoptosis. In addition
to diabetes, these mice exhibit other metabolic abnormal-
ities, including hyperlipidemia and hepatosteatosis. In
vitro experiments show that Sec61a1 plays an important
role in the -cell response to ER stress and glucose.
Although Sec61 is an essential gene in yeast, this study
shows that a single amino acid alteration within one of the
mammalian paralogs is not lethal and has profound meta-
bolic consequences, most evident in the pancreatic -cell.
RESEARCH DESIGN AND METHODS
Generation, housing, and diet of mice. ENU-mutagenized C57BL/6J mice
were generated as described (11). Mice were maintained by backcrossing
affected animals to C57BL/6J and housed in the Genomics Institute of the
Novartis Research Foundation Speciﬁc Pathogen-Free animal facility. All
procedures were approved by the Genomics Institute of the Novartis Research
Foundation Institutional Animal Care and Use Committee. Diets used in this
study were chow (PicoLab Rodent Diet 20 no. 5053; LabDiet) and high-fat diet
(HFD; D12331; Research Diets). Transgenic RIP-Sec mice were generated at
the Scripps Research Institute by microinjecting linearized plasmid DNA into
C57BL/6J pronuclei according to standard procedures.
Phenotyping of mice. Plasma from 4–6 h fasted mice was used for glucose,
triglyceride, and cholesterol determination on a clinical blood chemistry
analyzer (AU400e; Olympus). A duplicate sample was used for insulin enzyme-
linked immunosorbent assay (Crystalchem). Nonfasted blood glucose was
monitored using a OneTouch Ultra glucometer (LifeScan). Body composition
analysis was performed using the EchoMRI-100 whole-body composition
analyzer (EchoMRI).
Mapping and genotyping. Single nucleotide polymorphism assays (n  356)
were performed using the Sequenom MassARRAY system as previously
described (12). All exons of Sec61a1 were ampliﬁed by PCR and sequenced
for mutation detection. Speciﬁcally for genotyping, exon 10 was ampliﬁed
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Histology and immunohistochemistry. Liver and pancreas were ﬁxed in
10% phosphate-buffered formalin for 24 h and embedded in parafﬁn, and 5-m
sections were prepared and stained using hematoxylin-eosin or Masson-
Trichrome. Pancreatic sections were immunostained as previously described
(13). Antibody combinations were as follows: rabbit anti-insulin (sc-9168;
Santa Cruz Biotechnology) and AlexaFluor 594–conjugated chicken anti-
rabbit antibody; goat anti-glucagon antibody (sc-97780; Santa Cruz Biotech-
nology) and AlexaFluor 488–conjugated donkey anti-goat antibody; goat
anti-SEC61A1 antibody (ab1327; Abcam) and AlexaFluor 488–conjugated
donkey anti-goat antibody; anti-immunoglobulin heavy chain–binding protein
(BIP) antibody (sc-1050; Santa Cruz Biotechnology) and AlexaFluor 488–
conjugated donkey anti-goat antibody; anti-C/EBP homologous protein
(CHOP) antibody (sc-7351; Santa Cruz Biotechnology) and AlexaFluor 488–
conjugated goat anti-mouse antibody. Fluorescent transferase-mediated dUTP
nick-end labeling (TUNEL) staining was performed using the DeadEnd
Fluorometric TUNEL System kit (G3250; Promega). All sections were stained
with DAPI and mounted in Vectashield (Vector Labs).
Pancreatic islet puriﬁcation. Pancreatic islets were isolated as previously
described (13).
Electron microscopy. Isolated islets or dissected liver was processed for
electron microscopy using a modiﬁcation of the protocol by Gilula et al. (13a).
Tissue was ﬁxed in 4% paraformaldehyde, 1.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer (pH 7.3), washed and ﬁxed in 1% osmium tetroxide/0.1 mol/l
sodium cacodylate, subsequently treated with 0.5% tannic acid, followed by 1%
sodium sulfate, buffer washed, and then dehydrated in graded ethanol. During
the dehydration, islets were transferred to a microfuge tube for subsequent
treatment. After incubation in propylene oxide and overnight inﬁltration in
Epon/araldite, the resin pellets were polymerized at 60°C. Pellets were
removed and reembedded in ﬂat embedding molds. Thin sections (70 nm)
were cut on a Reichert Ultracut E (Leica) using a diamond knife (Diatome;
Electron Microscopy Sciences), mounted on parlodion-coated, copper slot
grids, and stained in uranyl acetate and lead citrate. Sections were examined
on a Philips CM-100 TEM (FEI, Hillsboro, OR) and data documented on Kodak
SO-163 ﬁlm.
MIN6 cells, transfection, and thapsigargin. MIN6 cells were obtained from
Dr. J. Miyazaki, Osaka University, and cultured as described (14). Min6 cells
were transfected with Lipofectamine 2000 according to package protocol
(Invitrogen). ER stress-inducer thapsigargin was obtained from Sigma.
Antibodies. Mouse monoclonal anti-FLAG clone M2 and anti-insulin clone
K36AC10 were purchased from Sigma. Rabbit polyclonal anti-pEIF2 and
mouse monoclonal total EIF2 were obtained from Invitrogen. Western blot
images were quantiﬁed using ImageJ software (National Institutes of Health).
Metabolic labeling of insulin in Min6 cells and immunoprecipitation.
Min6 cells were maintained in high-glucose Dulbecco’s modiﬁed Eagle’s
medium (DMEM) and transfected with the indicated construct in 35-mm
dishes. Prior to labeling cells were starved for 30 min in Met- and Cys-free
media and then pulsed with 50 Ci of easy tag express labeling mix for 30 min
(Perkin Elmer). Cells were then chased for the indicated times in DMEM with
10% FBS. Cells were lysed in radioimmunoprecipitation assay buffer and
immunoprecipitated with mouse monoclonal anti-insulin followed by the
addition of Protein A/G (Calbiochem) agarose.
Luciferase assay. Min6 cells were transfected in triplicate in opaque, white
96-well plates. After 24 h, cells were treated with thapsigargin for 16 h. Fireﬂy
and Renilla luciferase activity was then determined using the Dual-Glo kit
(Promega) and an Acquest luminometer (Molecular Devices).
Quantitative RT-PCR. All RNA was collected and extracted using an RNeasy
kit (Qiagen). Quantitative PCR (qPCR) reactions were performed using
SuperScript III Platinum One-Step qRT-PCR Kit (Invitrogen) and ABI PRISM
7900HT Sequence Detection System (Applied Biosystems, Foster City, CA)
according to manufacturer’s protocol. The reagents for analysis of mouse Bip
were obtained as a commercially available Taqman Gene Expression Assay
(Mm00517691_m1). In MIN6 cells, Sec61a1 was analyzed using the oligonu-
cleotides 5-TCAGCATCAGGGCCAGAT-3 and 5-AGACAAGGCCACGTGT
GATAT-3 and the probe 5-CACACAGCCCAGGGCGCACA-3. In transgenic
mice, Sec61a1 was analyzed using a Taqman gene expression assay
(Mm00489804_m1) from Applied Biosystems. Expression values were normalized
to a housekeeping gene 36B4, which was analyzed using the oligonucleo-
tides 5-AGATGCAGCAGATCCGCAT-3 and 5-GTTCTTGCCCATCAG
CACC-3 and the probe 5-CGCTCCGAGGGAAGGCCG-3. Primers and
probes for qPCR analysis of Bip and Chop in islets and livers were obtained
from Applied Biosystems.
RESULTS
Identiﬁcation of Sec61a1 mutation and metabolic
abnormalities in ENU-mutagenized mice. In a forward-
genetic screen using C57BL/6J mice, we identiﬁed a family
of animals that exhibited hyperglycemia when fed a HFD.
Affected mice were bred to 129/SvJ mice to generate
hybrid F2s. A genome scan using single nucleotide poly-
morphisms in nine unaffected and four affected mice
identiﬁed a 50-Mb locus on chromosome 6 (supplementary
Fig. 1A, available in an online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db08-1362/DC1) that
was inherited with the diabetic phenotype. Haplotype
analysis of a further 140 F2 hybrid mice reﬁned this
locus to 4.7 Mb, between 88.1 and 92.8 Mb, a region
containing 60 genes. We chose to sequence those genes
enriched in pancreatic islets (http://symatlas.gnf.org),
including Sec61a1. A homozygous missense mutation was
identiﬁed within exon 10 of Sec61a1 in affected animals
(supplementary Fig. 1B). The T to C transition at codon
344 results in a Tyr to His (Y344H) amino acid substitution
within Sec611.
Sec611 is highly conserved with orthologs from other
animals and with the mouse paralog Sec612 (Fig. 1A).
The Y344H mutation identiﬁed in the diabetic mice is
localized to a double Tyr motif, present in all species
analyzed, suggesting a crucial role for these two amino
acids in Sec611 function. Sec61a1
Y344H/Y344H mice exhib-
ited hyperglycemia, most likely due to insulin insufﬁ-
ciency, as shown by hypoinsulinemia in the same mice
(Fig. 1B, supplementary Table 1). Although heterozygous
Sec61a1 mice were not diabetic, they did display an
intermediate hypoinsulinemic phenotype on HFD (Fig. 1B,
supplementary Table 1). A time course of fasting blood
glucose levels indicated that hyperglycemia appeared at an
early time point in both males and females (Fig. 1C). This
observation taken together with the profound hypoinsu-
linemia in mutant animals indicated that diabetes was due
to -cell failure.
Immunohistochemistry in pancreatic sections from nor-
mal mice conﬁrmed islet expression of Sec611. Double
staining of islets for Sec611 and insulin showed that
Sec611 is highly expressed in -cells (Fig. 1D). Surpris-
ingly Sec61a1 expression appeared much higher in islets
then the surrounding acinar cells of the pancreas. qPCR,
however, veriﬁed that islets exhibited an 4.0-fold higher
expression of Sec61a1 compared with whole pancreas
(Fig. 1E). A tissue survey of Sec61a1 expression by qPCR
revealed that Sec61a1 was nevertheless expressed in
whole pancreas at levels equal with many other tissues,
afﬁrming that Sec611 is expressed at exceptionally high
levels in -cells. Furthermore, qPCR performed on differ-
ent tissues revealed that the 2 paralog was not expressed
at higher levels in mutant mice than in wild-type mice and
that the 2 paralog was expressed at relatively low levels
in every tissue analyzed with the exception of whole brain
(Fig. 1F).
Although diabetes was the most prominent phenotype
in Sec61a1
Y344H/Y344H mice, it was accompanied by multi-
ple endocrinological and growth abnormalities (for both
sexes on both chow and HFD; supplementary Table 1).
Sec61a1
Y344H/Y344H mice were smaller than wild-type litter-
mates; both fat and muscle mass were reduced, 66 and
25%, respectively, in males fed a HFD (supplementary
Table 1), resulting in 28% lower body weights. Also,
Sec61a1
Y344H/Y344H mice were hypercholesterolemic and
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FIG. 1. Sec61a1 is a conserved -cell gene whose
mutation is associated with diabetes due to hypoin-
sulinemia. A: Amino acid comparison of mouse
Sec611 residues 330–360 to the paralog mSec612
and orthologs (h, human; x, Xenopus; y, yeast; b,
bacteria). The asterisk shows Tyr344. B: Fasted
plasma glucose and insulin were analyzed in
Sec61a1
/ (wild type), Sec61a1
/Y344H (HET), and
Sec61a1
Y344H/Y344H (MUT) mice, aged 12 weeks, fed
HFD. Males (n  4–10); females (n  9–13). Values
shown are means  SEM. Statistical assessments
were made using a two-tailed Student t test assuming
unequal variances (versus sex-matched wild-type lit-
termates); *P < 0.01, **P < 0.001. C: Glucose levels
are elevated early in Sec61a1
Y344H/Y344H mice
(squares) compared with Sec61a1
/ (diamonds) an-
imals. Values shown are means  SEM. Statistical assessments were made using a two-tailed Student t test assuming unequal variances (versus
wild-type littermates). D: Immunohistochemistry in islets shows Sec611 (middle) is highly expressed speciﬁcally in -cells (as shown by insulin
staining). Merged image shows colocalization. Slides were counterstained with DAPI (200 magniﬁcation). E: qPCR of Sec611 from RNA
isolated from islets (n  4) and whole pancreas (n  3) in age- and sex-matched Sec61a1
/ mice. Relative expression levels of the indicated
genes were determined by comparative threshold cycle (Ct) analysis. Values shown are means  SD. Statistical assessment was made using a
two-tailed Student t test assuming unequal variances. *P < 0.01. F: qPCR of Sec611 and Sec612 from age- and sex-matched Sec61a1
/ and
Sec61a1
Y344H/Y344H mice (n  2 each genotype). Relative expression levels were determined by comparative Ct analysis. Values shown are means 
SD. (A high-quality color representation of this ﬁgure is available in the online issue.)
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atosis, and, in older mice, hepatic cirrhosis was evident
(supplementary Fig. 2).
Loss of -cells is due to apoptosis in Sec61a1 mutant
mice. Because hyperglycemic Sec61a1
Y344H/Y344H mice
had low circulating insulin concentrations, we chose to
focus on the cellular composition of the pancreatic islets
of Langerhans. Sec61a1
Y344H/Y344H mice were born with
islets composed of a typical population of - and -cells
(Fig. 2A). However, by 3 months of age (after HFD
feeding), there was a dramatic reversal of the - and -cell
populations in Sec61a1
Y344H/Y344H mice. Only 15% of cells
in islets from Sec61a1
Y344H/Y344H mice were -cells, in
contrast to 80% in a wild-type mouse islet (Fig. 2B). We
also observed an increase in the number of somatostatin-
expressing -cells (supplementary Fig. 3A). These addi-
tional -cells were found to be mislocalized to the interior
of the islet, rather than their typical peripheral position.
The -cell loss, insulin insufﬁciency, and development of
hyperglycemia are characteristic of type 1 diabetes, and
immune destruction within islets. We did not, however,
detect any evidence of insulitis in islets from
Sec61a1
Y344H/Y344H mice (data not shown). We did observe
multiple apoptotic -cells in islets from mutant mice (Fig.
2C), but not in islets from wild-type mice. Consistent with
increased apoptosis, we also detected cells positive for
activated caspase-3 in Sec61a1
Y344H/Y344H islets (supple-
mentary Fig. 3B) but not in wild-type. This increase in
A
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FIG. 2. Sec61a1
Y344H/Y344H mice lose -cells by apoptosis and exhibit signs of ER stress.
A: Islets from neonate, 4-, 7-, and 12-week-old wild-type (/) and mutant (Y344H/
Y344H) mice fed HFD stained for insulin (red), glucagon (green), and nuclei (blue)
(600 magniﬁcation). B: Quantitation of islet composition from 12- to 15-week-old
sex-matched mice fed HFD (n  3 mice each genotype, 10 islets each). Error bars
represent SD. C: Quantitative assessment of TUNEL
 -cells in islets from three
wild-type (/) and three mutant (Y344H/Y344H) mice aged 4 weeks and fed HFD for
1 week. Data are expressed as the number of TUNEL
 cells per islet. Statistical
assessment was made using a two-tailed Student t test assuming unequal variances.
*P < 0.01. D: Glucagon levels measured from 12-week-old sex-matched mice on HFD
(n  5 MUT; n  6 wild type). Values shown are means  SEM. E: Islets from 4-week-old
wild-type (/) and mutant (Y344H/Y344H) mice fed HFD for 1 week stained for
markers of ER stress (Bip [left two columns; green] and Chop [right two columns;
green]), insulin (red), and nuclei (blue) (600 magniﬁcation). Arrows highlight those
-cells with high expression of either Bip or Chop. F: Electron microscopy of -cells
from islets isolated from a wild-type (/) and mutant (Y344H/Y344H) mice aged 6
months. Note normal secretory granule (g) morphology, but marked ER dilation. Inset:
blowup of the ER membrane demonstrating ribosomes (arrowheads) free in the cytosol
and bound to the ER membrane. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
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levels of glucagon in the plasma of fasting HFD-fed
mice, although this did not reach signiﬁcance, which
could possibly contribute to the hyperglycemic pheno-
type (Fig. 2D).
ER stress in Sec61a1 mutant mice. Because Sec611
plays a role in ER function and protein processing, we
investigated ER stress in Sec61a1
Y344H/Y344H islets. Immuno-
histochemical staining of islets from 4-week-old
Sec61a1
Y344H/Y344H mice showed that the ER stress mark-
ers Bip and Chop were upregulated in -cells from mutant
mice (Fig. 2E arrows) compared with -cells from wild-
type littermates. ER stress was also assessed by electron
microscopy of individual Sec61a1
Y344H/Y344H -cells. Con-
sistent with the upregulation of Bip and Chop, the ER of
mutant -cells was massively distended with large pools
of ER lumen easily visible (Fig. 2F). Thus, the increased
apoptosis in Sec61a1
Y344H/Y344H islets was associated with
increased ER stress. Note also that ribosomes engaged the
ER despite a mutation in Sec611 (Fig. 2F, high-magniﬁ-
cation inset).
Islet-speciﬁc expression of wild-type Sec61a1 res-
cues diabetes and -cell apoptosis but not liver pa-
thology. To conﬁrm a causative role for the Y344H
mutation in -cell death and diabetes, we attempted to
rescue the diabetic phenotype in mutant mice by express-
ing wild-type Sec61a1 speciﬁcally in -cells using the rat
insulin promoter (RIP-Sec, supplementary Fig. 4) (15).
Transgene-speciﬁc RT-PCR showed expression of the
transgene speciﬁcally in islets (supplementary Fig. 4C),
whereas qPCR, which does not distinguish between the
endogenous gene product and the product of the trans-
gene, showed increased expression of Sec61a1 in -cells,
but not liver, of transgenic animals compared with wild
type (Fig. 3A). Hyperglycemia was apparent in 8-week-old
HFD Sec61a1
Y344H/Y344H mice compared with Sec61a1
/
controls and becomes progressively worse through 20
weeks, but mutant mice that express the RIP-Sec trans-
gene (Sec61a1
Y344H/Y344H, Tg[Rip-Sec61]) maintained nor-
mal glycemia throughout the 20-week time course of the
experiment (Fig. 3B). Compared with wild-type controls,
mutant mice were hypoinsulinemic between 8 and 20 weeks
(Fig. 3C). Although insulin levels in Sec61a1
Y344H/Y344H,
Tg[Rip-Sec61] mice were lower than wild-type mice during
this time, insulin secretion was sufﬁcient to maintain
normal glycemia up to 20 weeks of age (Fig. 3B and C).
Because hyperglycemia and hypoinsulinemia in mutant
mice were due to a loss of -cells, we next asked whether
transgenesis would rescue -cell loss. At 24 weeks of age,
mutant mice possessed far fewer -cells compared with
wild-type mice, with a concomitant expansion of gluca-
gon-secreting -cells. This -cell loss, however, was
blocked by transgenic expression of wild-type Sec61a1
(Fig. 3D).
The other prominent phenotype of mutant mice was
hepatic steatosis, cirrhosis, and hepatomegaly (supple-
mentary Fig. 2). These liver phenotypes could be a primary
result of Sec61a1 mutation in the liver or they could be
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measured for each genotype and the values shown are means  SEM. Statistical assessments were made using a two-tailed Student t test assuming
unequal variances (versus mutant littermates); *P < 0.05, **P < 0.005. D: Pancreata from 24-week-old Sec61a1
/ (/), Sec61a1
Y344H/Y344H
(Y344H/Y344H), and Sec61a1
Y344H/Y344H, Tg[RIP-Sec61] (Y344H/Y344H, RIP-Sec61) mice stained for insulin (red) and glucagon (green) (400
magniﬁcation). (A high-quality digital representation of this ﬁgure is available in the online issue.)
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between these possibilities, we examined livers of
Sec61a1
/, Sec61a1
Y344H/Y344H, and Sec61a1
Y344H/Y344H,
Tg[Rip-Sec61] mice. Although RIP-Sec61 transgenesis res-
cued diabetes, it did not affect steatosis or cirrhosis (Fig.
4A). Likewise hepatomegaly was only mildly affected by
RIP-Sec61 transgenesis (Fig. 4B).
Transgenic rescue of the body weight and fat mass
deﬁcits of mutant mice was only partial, as -cell–speciﬁc
expression of wild-type Sec61a1 increased the body
weight and lean mass of mutants but not to the level of
wild-type mice (Fig. 4C).
RIP-Sec61 transgenesis protects -cells but not hepa-
tocytes from ER stress. We next examined -cells and
hepatocytes of Sec61a1
/, Sec61a1
Y344H/Y344H, and
Sec61a1
Y344H/Y344H, Tg[Rip-Sec61] for signs of ER stress.
Because HFD can itself lead to ER stress in the liver (17),
we conducted these experiments on chow diet to avoid
any confounding inﬂuence of HFD. Mice still develop
hyperglycemia, hypoinsulinemia, glucose intolerance, and
-cell loss on chow diet (supplementary Table 1, supple-
mentary Fig. 5, and data not shown). ER in mutant -cells
was severely distended compared with wild-type -cells (Fig.
5A, center and left). This ER distension was almost com-
pletely rescued by transgenesis, with slight distension of the
ER still visible by electron microscopy (Fig. 5A, right).
Consistent with the rescue of ER stress shown by electron
microscopy, mRNA of the ER stress response genes Bip and
Chop was not elevated in islets from Sec61a1
Y344H/Y344H,
Tg[Rip-Sec61] mice compared with wild-type mice (Fig.
5B) at 3 months of age. In fact, there was a small but
signiﬁcant decrease in Chop expression in rescued mice
(Fig. 5B).
ER in mutant livers was also distended compared with
wild-type liver (Fig. 5C, center) and transgenic expression
of wild-type Sec61a1 in -cells did not noticeably affect
this distension (Fig. 5C, right). Finally, qPCR for Bip and
Chop revealed upregulation of both these genes in
Sec61a1
Y344H/Y344H and Sec61a1
Y344H/Y344H, Tg[Rip-Sec61]
mice compared with wild type (Fig. 5D). These data
illustrate that sufﬁcient expression of wild-type Sec611
protects -cells from ER stress present in Sec61a1
Y344H/Y344H
mice. Furthermore, these data support the notion that
steatosis and hepatomegaly in this model are a direct result
of Sec611 mutation and ER stress in the liver, and not
secondary to diabetes.
Sec611
Y334H sensitizes -cells to ER stress but does
not affect insulin processing. We next examined the
effect that Sec611
 and Sec611
Y344H have on -cells in
vitro. For this, we cloned both Sec611
and Sec611
Y344H
into expression vectors and overexpressed each in a
physiologically relevant -cell line. MIN6 cells were ideal
for this purpose as we were able to establish relatively
high levels of transient transfection (50%, data not
shown) and these cells maintain the ability to secrete
insulin in response to high glucose concentration (18).
First, we wanted to establish whether overexpression of
Sec611
Y344H led to ER stress in Min6 cells. For this, we
used two different luciferase-based promoter activation
assays and Western blot for phosphorylated Eif2. These
assays were chosen to allow us to delineate activation of
different arms of the ER stress response, because in
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three different sentinels Ire-1, Atf6, and Perk (19). Eif2
phosphorylation is a direct consequence of Perk activa-
tion, the ER stress response element (ERSE) is preferen-
tially activated by Atf6 binding, and the unfolded protein
response element (UPRE) is activated by Xbp-1, which is
activated by Ire-1 in response to ER stress (20,21). MIN6
cells were cotransfected with plasmids expressing FLAG-
tagged Sec61
, Sec61
Y344H, or empty vector, and a lucif-
erase reporter vector containing either the ERSE element
or the UPRE element. We also included Renilla luciferase
under the control of the cytomegalovirus (CMV) promoter
to serve as an internal control for transfection efﬁciency
and cell viability. Cells were then treated with thapsigar-
gin, a pharmacological inducer of ER stress, followed by
quantitation of ﬁreﬂy and Renilla luciferase activity. Inter-
estingly, overexpression of Sec611
Y344H signiﬁcantly
increased signaling through UPRE compared with
Sec611
- or vector-transfected Min6 cells, both under
basal conditions and in response to the ER stress-inducer
thapsigargin (Fig. 6A). The effect of Sec611 on the ERSE
reporter is less clear as neither Sec611
 nor
Sec611
Y344H overexpression increased signaling through
this response element. Sec611
, however, reduced sig-
naling through ERSE in response to thapsigargin-induced
ER stress and Sec611
Y344H was less effective at mitigating
ER stress signaling in this pathway (Fig. 6A). To examine
Perk activation via Eif2 phosphorylation we transfected
Min6 cells with Sec61
, Sec61
Y344H, or empty vector and
treated them with thapsigargin for 4 h. Western blot
analysis using a phospho-speciﬁc antibody revealed en-
hanced Eif2 phosphorylation in Min6 transfected with
Sec611
Y344H (Fig. 6B). Quantifying the Western signals
showed that thapsigargin increased phosphorylation of
Eif2 almost 50% more in the presence of Sec611
Y344H
than in the presence of wild-type Sec611 (Fig. 6B).
These results indicated that mutant Sec611 sensitized
Min6 cells to the effects of ER stress. Because Sec611
mediates entry into the secretory pathway and insulin is
the major protein secreted from -cells, we sought to
determine whether aberrant insulin processing might lead
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/ (/), Sec61a1
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mice. Total RNA was extracted from isolated islets of age- and sex-matched mice from each genotype (n  2). Relative expression levels of the
indicated genes were determined by comparative Ct analysis. Values shown are means  SD. Statistical assessments were made using a two-tailed
Student t test assuming unequal variances. *P < 0.01. C: Electron microscopy of livers from Sec61a1
/ (/), Sec61a1
Y344H/Y344H (Y344H/
Y344H), and Sec61a1
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Y344H/Y344H, Tg[RIP-Sec61] (Y344H/Y344H, RIP-Sec61) mice. Total RNA was extracted from livers
of age- and sex-matched mice from each genotype (n  2). Relative expression levels of the indicated genes were determined by comparative Ct
analysis. Values shown are means  SD. Statistical assessments were made using a two-tailed Student t test assuming unequal variances. *P < 0.01.
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vector, Sec61
, or Sec61
Y344H, labeled them with
35S-
labeled Cys, and assayed insulin processing 0, 30, 60, and
120 min after chase with unlabeled Cys to determine
whether insulin processing was inﬂuenced by the mutant
Sec61. Because insulin is translated as a single polypeptide
(proinsulin) and not fully processed to its mature form
until it is transported to secretory granules, any temporal
delay in insulin processing from its pro form would
indicate that insulin folding/quality control is corrupted by
the mutant Sec61 protein. In fact, pulse-chase labeling of
insulin revealed that there is no noticeable defect in
insulin processing in cells transfected with mutant Sec61
compared with both wild-type and vector-transfected cells
(Fig. 6C). These results indicate that ER stress apparent in
both primary -cells and -cell lines as a result of mutant
Sec61 is not a result of improper folding, quality control, or
transport of insulin.
Finally, given the effect Sec611 had on ER stress
signaling in MIN6 cells we next wanted to know whether
Sec611 is regulated in response to ER stress or high
glucose. MIN6 cells were cultured in low-glucose DMEM
and treated with thapsigargin. A time course of mRNA
levels for Sec61a1 indicates that this gene is upregulated
in response to ER stress concomitant with Bip, a canoni-
cal ER stress response gene (Fig. 6D). Furthermore, the
level of Sec61a1 and Bip mRNA reached after 10 h of
thapsigargin treatment is equivalent to that of 10 h of
culture in high-glucose DMEM (Fig. 6D, right).
DISCUSSION
In this report we have used ENU mutagenesis to identify a
mutation in the Sec61a1 gene that leads to diabetes and
hepatosteatosis in homozygous mutant mice. Diabetes in
this model is a result of insulin insufﬁciency that is caused
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apoptosis was a result of ER stress in pancreatic islets, and
that islet-speciﬁc expression of wild-type Sec611 not only
rescued hyperglycemia and the -cell composition of islets
in mutant mice, but also rescued ER stress. Experiments
in vitro in MIN6 cells reveal that Sec61
Y3344H is directly
responsible for a dysregulated ER stress response in
-cells. Furthermore, we have shown that Sec61a1 is an
ER stress response gene in -cells, and is responsive to
high glucose conditions.
Sec611 mutation also led to ER stress in hepatocytes
as evidenced by electron microscopy and qPCR. TUNEL
staining revealed that elevated ER stress led to a higher
rate of apoptosis in hepatocytes from mutant mice (sup-
plementary Fig. 6A), however, in this case, apoptosis was
compensated for by increased proliferation in mutant mice
(supplementary Fig. 6B) as indicated by bromodeoxyuri-
dine incorporation. Thus, through islet-speciﬁc rescue of
diabetes we have also uncovered a fatty liver phenotype
that is a primary result of Sec611 mutation and ER stress,
not hyperglycemia.
Because Sec611 is involved in the translocation of
newly synthesized polypeptides into the ER lumen, it is
likely that some protein important for -cell function is
being improperly folded, partitioned into the membrane,
or transported from the ER. A likely culprit in -cells is
misfolded/misprocessed insulin. The presence of dense
staining secretory granules, however, being normal in both
number and appearance, in electron micrographs (Fig. 2F)
suggests that formation of insulin secretory granules is
unaffected in mutants, and pulse labeling in MIN6 cells
(Fig. 6C) indicates insulin processing is unaffected by this
particular Sec611 point mutant. Additionally, the insulin
in these -cells is fully processed and disulﬁde bonded as
determined by nonreducing PAGE of islet lysates from
4-week-old Sec61a1
Y344H/Y344H mice prior to complete -cell
loss (supplementary Fig. 7). This is in contrast to a
situation in which defects in the production and secretion
of mature insulin leads to glucose intolerance due a
defective response to ER stress (22). In this case a serine
in Eif2 is substituted with alanine (S51A) such that Eif2
is not phosphorylated by Perk, and translation is not
attenuated, in response to ER stress. This failure to
attenuate translation in the face of increased secretory
burden of the -cell brought on by diet-induced insulin
resistance leads to a saturation of the ER’s capacity to fold
and process proteins, in turn leading to a reduction of
insulin in secretory granules (22). Likewise, the observa-
tion that mice respond to intraperitoneal injection of
insulin implies that insulin receptor and GLUT trafﬁcking
is not impaired in mutant mice (supplementary Fig. 5A).
Rather than a defect in ER import or secretion of insulin
or some component necessary for -cell survival, our data
suggest that -cell apoptosis is due to generalized ER
stress. ER stress is caused by the accumulation of un-
folded proteins in the ER (19). The cell responds to ER
stress by 1) attenuating translation, 2) increasing the
capacity of the ER to process proteins, by upregulating
folding chaperones, and 3) increasing the rate at which
unfolded proteins are removed and degraded. Collectively,
these adaptations are called the unfolded protein response
(UPR) (19). If the UPR does not relieve ER stress, apopto-
sis occurs, and in the case of -cell loss, diabetes develops.
An increasing body of evidence has shown that the
-cell is sensitive to ER stress (23–25). Indeed ER stress
has been implicated in several monogenic forms of diabe-
tes in humans. These include two human pleiotropic
syndromes associated with early-onset diabetes, Wolfram
syndrome (caused by mutations in WFS1) (26,27) and
Wolcott-Rallison syndrome (caused by mutations in
EIF2AK3/PERK) (28,29), and neonatal diabetes caused by
mutations in the proinsulin gene itself (30–32), which
prevent proper folding and/or disulﬁde bonding of mature
insulin. Recently, several studies have shown an associa-
tion between the development of type 2 diabetes and
variation in the WFS1 gene (33,34). ER stress and -cell
apoptosis have also been linked to diabetes in human
autopsy studies showing an increase in CHOP staining and
ER expansion (35,36). Furthermore islets from diabetic
individuals show elevation of ER stress markers BIP,
CHOP, and XBP1 in response to high glucose conditions
to a greater extent then in nondiabetic subjects (37).
This particular mutation in Sec611 occurs in a dity-
rosine motif that is conserved in the Sec611 protein
sequence of every homolog we have examined (sampled in
Fig. 1A), suggesting that it is critical for proper function.
Being positioned on the luminal side of the ER membrane,
it is likely that this dityrosine facilitates an interaction with
a protein involved in maintaining ER homeostasis, such as
a chaperone or other protein involved in ER quality
control, or that it may contribute to some catalytic func-
tion of Sec611 itself.
Experiments shown here indicate that Sec611i su p -
regulated in response to both ER stress and high glucose
levels, indicating that Sec611 is part of a coordinated
-cell response to augmented secretory demand initiated
by elevated glucose levels. In fact, recent evidence sug-
gests that chronically elevated glucose levels lead to ER
stress and an ultimate attenuation of insulin production
(38,39). Glucose also leads to enhanced overall translation
in -cells through dephosphorylation of Eif2, apparently
independent of signaling through the UPR (40) and this
effect is not altered by Sec611
Y344H in MIN6 cells (data
not shown). Compromising Sec61 function only slightly
could lead to a positive feedback loop in which higher
levels of ER stress in response to transient hyperglycemia
result in lower levels of insulin production, which leads to
more severe hyperglycemia, which leads to greater stress
on -cells and ultimately -cell failure and overt diabetes.
That Sec611 expression is important for -cell survival is
supported by the observation that Sec61a1
Y344H/Y344H,T g
[Rip-Sec61] mice exhibit signiﬁcantly lower levels of Chop
mRNA compared with wild-type mice. This is important
considering genetic deletion of Chop, a proapoptotic tran-
scription factor upregulated by ER stress, leads to amelio-
ration of several models of ER stress–induced diabetes
and -cell loss (41).
Sec61a1
Y344H/Y344H mice also develop hepatomegaly, he-
patic steatosis, and cirrhosis, which could be secondary to
a lack of insulin signaling (16) or a direct result of Sec61a1
mutation in hepatocytes. Our data show that they are a
direct result of mutation in the liver. Although it remains to
be determined whether steatosis is mediated by ER stress
in this model, hepatic steatosis associated with ER stress
has been noted in hyperhomocysteinemic (42), genetically
obese (43), HFD-fed (44,45), and genetically altered mice
lacking UPR response genes (46).
In summary, we have presented genetic, physiological,
and molecular evidence that Sec611 is important for
-cell survival in response to hyperglycemia, and that
mutation of Sec611 leads to diabetes via -cell apoptosis
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This is also, to our knowledge, the ﬁrst Sec611 functional
mutation in a mammalian system that is not lethal. In the
future, this mouse model can be used to shed light on the
effect of abrogated Sec611 function in different tissues
and disease states.
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